By Laird Harrison, Medscape
Inhaled cannabis can blunt the pain of diabetic neuropathy without seriously impairing cognitive function, a new study shows.
“The higher the dose, the more the pain relief,” first author Mark Wallace, MD, told Medscape Medical News. “There was, however, a dose-dependent increase in euphoria.”
The study is the first randomized controlled trial of inhaled cannabis for diabetic neuropathy pain, said Dr Wallace, chair of the Division of Pain Management at the University of California, San Diego. It was published in the July issue of the Journal of Pain.